All In Biotech

Free tool

FAERS Monitor: Labetalol Hydrochloride

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213330 or its brand name (Labetalol Hydrochloride, Labetalol Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

13,484

Serious

10,245

76% of reports

Hospitalization

5,112

Death reported

1,375

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,060
  • maternal exposure during pregnancy1,001
  • foetal exposure during pregnancy976
  • hypertension767
  • premature baby752
  • off label use726
  • exposure during pregnancy672
  • chronic kidney disease646
  • acute kidney injury645
  • fatigue616
  • renal failure581
  • nausea555
  • headache519
  • premature delivery516
  • dyspnoea499

Reports by year received

View as table
YearReports
200459
2005137
200666
200742
200844
200954
201074
2011197
2012213
2013438
2014709
2015751
2016757
2017944
20181,068
20191,223
20201,144
20211,100
20221,017
2023908
2024956
2025857
2026726

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,675 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
premature deliverySignal51652.247.925,043
premature babySignal75239.937.227,844
foetal exposure during pregnancySignal97618.917.816,436
maternal exposure during pregnancySignal1,00117.716.715,652
exposure during pregnancySignal67217.015.810,050
chronic kidney diseaseSignal64613.412.47,343
renal failureSignal5816.96.32,903
acute kidney injurySignal6456.66.13,067
hypertensionSignal7675.75.32,962
dyspnoea4991.41.352
off label use7261.31.250
headache5191.31.235
drug ineffective1,0601.31.258
fatigue6161.21.128
nausea5551.11.05

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.